Oppenheimer Analyst Reaffirms Outperform Rating for Olema Pharmaceuticals
Oppenheimer analyst Matthew Biegler has once again endorsed Olema Pharmaceuticals (NASDAQ: OLMA) with a positive Outperform rating and a price ...
Tag: OLMA
Citigroup Analyst Initiates Coverage on Olema Pharmaceuticals with a Buy Rating and 20 Price Target
On January 30, 2024, Yigal Nochomovitz, an esteemed analyst at Citigroup, made a significant move by initiating coverage on Olema ...
Vontobel Holding Ltd. Reduces Stake in Olema Pharmaceuticals: Examining Challenges and Potential for Growth
Vontobel Holding Ltd., a renowned Swiss international financial service company, has made significant changes to its investment portfolio by reducing ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
